title: Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse.
abstract: Four polyclonal antibodies raised against purified mouse liver cytochrome P450s representing Cyp1a, Cyp2a, Cyp2b and Cyp2c subfamilies were used to detect their related forms in human adult and fetal tissues. In immunoblot analysis, anti-Cyp2c antibody detected two to three proteins in adult livers and one to three proteins in 70% of the 18 fetal livers studied. Anti-Cyp2a-5 antibody recognized a 50-kDa protein in 50% of the fetal adrenals. Anti-Cyp1a-2 antibody reacted with a single protein (55 kDa) in adult liver. The anti-Cyp2b-10 antibody did not detect proteins in any of the tissues. No proteins were detected in fetal kidneys. There was no coumarin 7-hydroxylase activity (COH) in fetal liver or adrenals. The 7-ethoxycoumarin O-deethylase (ECOD) activities were slightly higher in fetal adrenals (mean 6.1 pmol/mg protein/min) vs livers. The fetal adrenal ECOD activity was not inhibited by the anti-Cyp2a-5 antibody. Aryl hydrocarbon hydroxylase (AHH) activities in fetal livers were about 5% of those in adult livers. AHH activity in fetal liver was not inhibited by the anti-Cyp2c antibody. Testosterone 6 beta-hydroxylase activity was much lower in fetal liver than in adult liver (about 20 and 1700 pmol/mg protein/min, respectively). No immunoinhibition occurred in fetal adrenal progesterone hydroxylation, hepatic benzphetamine N-demethylation and hepatic ethylmorphine N-demethylation. These data suggest that members of the P450 subfamilies 1A, 2A and 2B are expressed at a very low level in fetal liver, and that fetal liver may contain members of the 2C subfamily.
authors.affiliation: Department of Pharmacology and Toxicology, University of Oulu, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Mäenpää
authors.forename: A
authors.initials: A
authors.lastname: Rane
authors.forename: H
authors.initials: H
authors.lastname: Raunio
authors.forename: P
authors.initials: P
authors.lastname: Honkakoski
authors.forename: O
authors.initials: O
authors.lastname: Pelkonen
mesh_terms: D000311:Adrenal Glands / Q000196:embryology / Q000201:enzymology; D000328:Adult; D000368:Aged; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis* / Q000276:immunology; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D005333:Fetus / Q000201:enzymology*; D005865:Gestational Age; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000276:immunology; D008099:Liver / Q000196:embryology / Q000201:enzymology; D008297:Male; D051379:Mice; D008861:Microsomes / Q000187:drug effects; D008875:Middle Aged; D010634:Phenobarbital / Q000494:pharmacology
chemical_list: D000906:Antibodies; D065607:Cytochrome P-450 Enzyme Inhibitors; D007527:Isoenzymes; D003577:Cytochrome P-450 Enzyme System; D010634:Phenobarbital